A. Yu. Sedova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
A. Yu. Sedova has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Aleksander B. Malakhov
Sechenov First Moscow State Medical University
3 shared publications - Natalia G. Kolosova
Sechenov First Moscow State Medical University (Sechenov University)
3 shared publications - Veronika D. Denisova
Sechenov First Moscow State Medical University (Sechenov University); Research Clinical Institute of Childhood
3 shared publications - Irina V. Grebeneva
Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Irina V. Ozerskaia
Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Marina Dalgatovna Shakhnazarova
Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications
Latest Publications
- Open Access
- 27 February 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 282-292
Risk factors for severe community-acquired pneumonia in infants and preschool children
Introduction. The relevance of studying community-acquired pneumonia in children is associated with its high prevalence, despite timely prevention and effective approaches to the treatment of respiratory diseases. Factors influencing the severity of pneumonia are diverse and include comorbid pathology, early age of the child, the state of the immune system, etc.Objective. To identify and rank risk factors for severe community-acquired pneumonia in infants and preschool children.Materials and methods. This article presents the results of a retrospective analysis of 291 medical histories of children from 3 months to 7 years with community-acquired pneumonia. 83 children had severe CAP, of which 63 patients were hospitalized in the ICU.Results and discussion. The average age of a patient with community-acquired pneumonia was 33 months. Children from families with two or more children fell ill more often. On average, children were hospitalized for 4–5 days of illness. Concomitant diseases in children with CAP were quite common and often complicated the course of pneumonia. According to the results of our study, more than 70% of children were not vaccinated against pneumococcus, Haemophilus influenzae and influenza. We established significant linear relationships between the presence of bronchial obstruction and complications of CAP such as respiratory failure and transfer to the ICU (odds ratio (OR) 7.1; Cramer coefficient 0.40; relationship 0.005). It was shown that patients who received outpatient antibiotic therapy were less likely to require transfer to the ICU.Conclusion. Risk factors for severe community-acquired pneumonia and hospitalization in the ICU were: male gender, age under 2 years, lack of vaccination against pneumococcus, Haemophilus influenzae and influenza, combination of bronchial obstruction with CAP, presence of ENT pathology, lack of antibacterial therapy during prehospital stage, as well as the presence of a serious condition already upon admission.
- 27 February 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 282-292
Open AccessRisk factors for severe community-acquired pneumonia in infants and preschool children
Introduction. The relevance of studying community-acquired pneumonia in children is associated with its high prevalence, despite timely prevention and effective approaches to the treatment of respiratory diseases. Factors influencing the severity of pneumonia are diverse and include comorbid pathology, early age of the child, the state of the immune system, etc.Objective. To identify and rank risk factors for severe community-acquired pneumonia in infants and preschool children.Materials and methods. This article presents the results of a retrospective analysis of 291 medical histories of children from 3 months to 7 years with community-acquired pneumonia. 83 children had severe CAP, of which 63 patients were hospitalized in the ICU.Results and discussion. The average age of a patient with community-acquired pneumonia was 33 months. Children from families with two or more children fell ill more often. On average, children were hospitalized for 4–5 days of illness. Concomitant diseases in children with CAP were quite common and often complicated the course of pneumonia. According to the results of our study, more than 70% of children were not vaccinated against pneumococcus, Haemophilus influenzae and influenza. We established significant linear relationships between the presence of bronchial obstruction and complications of CAP such as respiratory failure and transfer to the ICU (odds ratio (OR) 7.1; Cramer coefficient 0.40; relationship 0.005). It was shown that patients who received outpatient antibiotic therapy were less likely to require transfer to the ICU.Conclusion. Risk factors for severe community-acquired pneumonia and hospitalization in the ICU were: male gender, age under 2 years, lack of vaccination against pneumococcus, Haemophilus influenzae and influenza, combination of bronchial obstruction with CAP, presence of ENT pathology, lack of antibacterial therapy during prehospital stage, as well as the presence of a serious condition already upon admission.
- Open Access
- 25 January 2024
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 96 (1) , 53-57
Vaping use-associated lung injury in a teenager. Case report
In the last 10–15 years, especially among young people, there has been an increase in the prevalence of vaping, which partially replaces the smoking of conventional cigarettes. The chemicals in vape liquids can provoke the development of non-infectious inflammatory pneumonitis. Symptoms of the disease usually appear within a few months after the start of smoking electronic cigarettes. Vape-associated lung disease is a clinical diagnosis and is established after the exclusion of other respiratory diseases. The article describes a clinical case of vape-associated lung injury in a 17-year-old teenager.
- 25 January 2024
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 96 (1) , 53-57
Open AccessVaping use-associated lung injury in a teenager. Case report
In the last 10–15 years, especially among young people, there has been an increase in the prevalence of vaping, which partially replaces the smoking of conventional cigarettes. The chemicals in vape liquids can provoke the development of non-infectious inflammatory pneumonitis. Symptoms of the disease usually appear within a few months after the start of smoking electronic cigarettes. Vape-associated lung disease is a clinical diagnosis and is established after the exclusion of other respiratory diseases. The article describes a clinical case of vape-associated lung injury in a 17-year-old teenager.
- 1 January 2023
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 18 (1) , 38-35
Experience of rehabilitation of children with lung damage associated with COVID-19 in the post-covid period
- 1 January 2023
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 18 (1) , 38-35
Experience of rehabilitation of children with lung damage associated with COVID-19 in the post-covid period
- Open Access
- 15 November 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 19,p. 122-129
Long-standing foreign body in the right bronchus of a 7-year-old girl
Foreign body aspiration (FB) is one of the leading causes of death from accidents among preschool children. Every year, up to 8% of children worldwide die as a result of foreign body aspiration. In developed countries, the mortality rate is lower, but the problem remains no less urgent due to the high attendance at emergency departments. Longstanding foreign bodies deserve special attention. The absence of an aspiration episode in the anamnesis of the disease, nonspecific respiratory symptoms, “X-ray negative” foreign bodies, as well as organic FB can complicate the diagnostic search. The article presents data from domestic and foreign literature on epidemiology, risk factors, clinical features, as well as modern approaches to the diagnosis and treatment of foreign body aspiration. The authors present their own clinical observation of a long-standing foreign body in the bronchus in a 7-year-old child. Prolonged cough and repeated episodes of bronchial obstruction for 4 years were regarded as the onset of bronchial asthma. The lack of effect from ongoing bronchodilator and anti-inflammatory therapy with high doses of inhaled glucocorticosteroids dictated the need to expand the diagnostic search, and therefore the child was sent for examination in a hospital to the pulmonology department of the Children’s Clinical Hospital I.M. Sechenov. During endoscopic examination, a metal spiral spring (7 mm in size) was found in the child and simultaneously removed, which was presumably within 4 years in the right bronchus. Over the next 6 months, bronchial obstruction did not recur, there were no complaints.
- 15 November 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 19,p. 122-129
Open AccessLong-standing foreign body in the right bronchus of a 7-year-old girl
Foreign body aspiration (FB) is one of the leading causes of death from accidents among preschool children. Every year, up to 8% of children worldwide die as a result of foreign body aspiration. In developed countries, the mortality rate is lower, but the problem remains no less urgent due to the high attendance at emergency departments. Longstanding foreign bodies deserve special attention. The absence of an aspiration episode in the anamnesis of the disease, nonspecific respiratory symptoms, “X-ray negative” foreign bodies, as well as organic FB can complicate the diagnostic search. The article presents data from domestic and foreign literature on epidemiology, risk factors, clinical features, as well as modern approaches to the diagnosis and treatment of foreign body aspiration. The authors present their own clinical observation of a long-standing foreign body in the bronchus in a 7-year-old child. Prolonged cough and repeated episodes of bronchial obstruction for 4 years were regarded as the onset of bronchial asthma. The lack of effect from ongoing bronchodilator and anti-inflammatory therapy with high doses of inhaled glucocorticosteroids dictated the need to expand the diagnostic search, and therefore the child was sent for examination in a hospital to the pulmonology department of the Children’s Clinical Hospital I.M. Sechenov. During endoscopic examination, a metal spiral spring (7 mm in size) was found in the child and simultaneously removed, which was presumably within 4 years in the right bronchus. Over the next 6 months, bronchial obstruction did not recur, there were no complaints.
- Open Access
- 26 February 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 58-63
The role of herbal medicines in treating cough in children
The physiological role of cough is to restore mucociliary clearance in the respiratory tract. However, if there are inflammatory changes against the background of a respiratory infection, cough may be non-productive and impair the patient’s quality of life. For a rational choice of drug, the true cause of cough should be determined on the basis of history, physical examination and, if necessary, additional instrumental/laboratory investigations. Modern phytopharmaceuticals are considered effective and safe for cough relief. Herbal medicines contain biologically active substances, which are incorporated into the metabolic processes of the body in a more natural way, in contrast to synthetic analogues. The article focuses on the effectiveness of an ivy leaf extract, which has a complex composition: it contains saponins, flavonoids, glycosides, as well as components of essential oils. Due to its composition, it has several effects: expectorant due to its secretolytic and mucolytic action, and antispasmodic based on the increased sensitivity of β2-adrenoreceptor cells of bronchial smooth muscle cells to endogenous and exogenous stimulation, on reducing intracellular calcium levels and bronchial relaxation. The efficacy of ivy leaf extract has been shown in a total of more than 20 clinical trials, mainly in children suffering from upper respiratory tract infections. Cough treatment aims at changing the rheological properties of the secretion and increasing the effectiveness of the cough. The good compatibility of herbal medicines with other drugs, including antibiotics, allows their use not only as monotherapeutic agents, but also in combination therapy for the treatment of cough in children.
- 26 February 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 58-63
Open AccessThe role of herbal medicines in treating cough in children
The physiological role of cough is to restore mucociliary clearance in the respiratory tract. However, if there are inflammatory changes against the background of a respiratory infection, cough may be non-productive and impair the patient’s quality of life. For a rational choice of drug, the true cause of cough should be determined on the basis of history, physical examination and, if necessary, additional instrumental/laboratory investigations. Modern phytopharmaceuticals are considered effective and safe for cough relief. Herbal medicines contain biologically active substances, which are incorporated into the metabolic processes of the body in a more natural way, in contrast to synthetic analogues. The article focuses on the effectiveness of an ivy leaf extract, which has a complex composition: it contains saponins, flavonoids, glycosides, as well as components of essential oils. Due to its composition, it has several effects: expectorant due to its secretolytic and mucolytic action, and antispasmodic based on the increased sensitivity of β2-adrenoreceptor cells of bronchial smooth muscle cells to endogenous and exogenous stimulation, on reducing intracellular calcium levels and bronchial relaxation. The efficacy of ivy leaf extract has been shown in a total of more than 20 clinical trials, mainly in children suffering from upper respiratory tract infections. Cough treatment aims at changing the rheological properties of the secretion and increasing the effectiveness of the cough. The good compatibility of herbal medicines with other drugs, including antibiotics, allows their use not only as monotherapeutic agents, but also in combination therapy for the treatment of cough in children.
- Open Access
- 1 January 2022
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 21 (7)
Experience in the Use of Irrigation Therapy for Acute Respiratory Viral Infection in Children
Objective of the Paper: To draw the attention of pediatricians, otorhinolaryngologists, general practitioners to the possibilities of irrigation therapy in the treatment of acute respiratory viral infections in children. Key points. Irrigation therapy is widely used for the prevention and treatment of acute infections of the upper respiratory tract in children, and is an effective and safe method. However, there are no indications in the clinical guidelines about the exact concentrations of saline solutions, the method of irrigation therapy, and its duration. For use in acute respiratory viral infections in children at different periods of the disease, it is preferable to use a slightly hypertonic solution of sea water in the form of a fine spray. In the acute period, irrigation therapy reduces the need for the use of decongestants and antibiotics. In the subacute and post-viral periods, it promotes the regeneration of the ciliary epithelium. Conclusion. The addition of Ascophyllum nodosum brown algae extract to solutions for irrigation therapy can increase the effectiveness of treatment, promote faster relief of inflammation in the nasal cavity, and restore the mucosa due to the anti-inflammatory, antimicrobial, and immunomodulatory properties of fucoidans. Keywords: acute respiratory viral infections, irrigation therapy, children, sea water, brown algae.
- 1 January 2022
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 21 (7)
Open AccessExperience in the Use of Irrigation Therapy for Acute Respiratory Viral Infection in Children
Objective of the Paper: To draw the attention of pediatricians, otorhinolaryngologists, general practitioners to the possibilities of irrigation therapy in the treatment of acute respiratory viral infections in children. Key points. Irrigation therapy is widely used for the prevention and treatment of acute infections of the upper respiratory tract in children, and is an effective and safe method. However, there are no indications in the clinical guidelines about the exact concentrations of saline solutions, the method of irrigation therapy, and its duration. For use in acute respiratory viral infections in children at different periods of the disease, it is preferable to use a slightly hypertonic solution of sea water in the form of a fine spray. In the acute period, irrigation therapy reduces the need for the use of decongestants and antibiotics. In the subacute and post-viral periods, it promotes the regeneration of the ciliary epithelium. Conclusion. The addition of Ascophyllum nodosum brown algae extract to solutions for irrigation therapy can increase the effectiveness of treatment, promote faster relief of inflammation in the nasal cavity, and restore the mucosa due to the anti-inflammatory, antimicrobial, and immunomodulatory properties of fucoidans. Keywords: acute respiratory viral infections, irrigation therapy, children, sea water, brown algae.